Search

Author/Creator Hirsch, F R

1. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. (31st December 2018)

Authors:
Wang, Y; Jiang, T; Qin, Z; Jiang, J; Wang, Q; Yang, S; Rivard, C; Gao, G; Ng, T L; Tu, M M; Yu, H; Ji, H; Zhou, C; Ren, S; Zhang, J; Bunn, P; Doebele, R C; Camidge, D R; Hirsch, F R
Journal:
Annals of oncology
Issue:
Volume 30:Number 3(2019)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer. (14th June 2018)

Authors:
Bonomi, P D; Gandara, D; Hirsch, F R; Kerr, K M; Obasaju, C; Paz-Ares, L; Bellomo, C; Bradley, J D; Bunn Jr, P A; Culligan, M; Jett, J R; Kim, E S; Langer, C J; Natale, R B; Novello, S; Pérol, M; Ramalingam, S S; Reck, M; Reynolds, C H; Smit, E F
Journal:
Annals of oncology
Issue:
Volume 29:Number 8(2018)
Page Start:
1701
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search